Oncology Institute (TOIIW) Shares Outstanding (Diluted Average) (2020 - 2026)

Oncology Institute (TOIIW) has 7 years of Shares Outstanding (Diluted Average) data on file, last reported at $101.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 32.04% year-over-year to $101.8 million; the trailing twelve-month figure through Mar 2026 stood at $101.8 million (up 32.04% YoY), and the FY2025 full-year result was $92.4 million, up 23.11% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $101.8 million, up from $92.4 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $101.8 million in Q1 2026 and bottomed at $73.4 million in Q1 2023.
• The 5-year median for Shares Outstanding (Diluted Average) is $75.5 million (2024), against an average of $79.3 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) retreated 8.51%; it then soared 32.04% in 2026.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $80.6 million in 2022, then dropped by 8.51% to $73.7 million in 2023, then climbed by 1.76% to $75.0 million in 2024, then increased by 23.11% to $92.4 million in 2025, then increased by 10.19% to $101.8 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $101.8 million (Q1 2026), $92.4 million (Q4 2025), and $89.3 million (Q3 2025), per Business Quant data.

Peer Comparison